The news that a major cause of inflammatory bowl disease (IBD) has been found has once again put this distressing medical ...
Up to 40% of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), with the ...
Ensho Therapeutics has presented additional data supporting NSHO-101, also referred to as EA1080, as an oral one-time-a-day ...
Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
Visitors attend a presentation by South Korean pharmaceutical giant Celltrion Inc. during the 2025 European Crohn's and ...
Larry Sears and Sally Zlotnick Sears recently donated $1 million to the Crohn’s and Colitis Foundation, according to a news release.
Long-term yogurt consumption is associated with a reduced risk of Bifidobacterium-positive colorectal cancer, particularly in ...
Academic Matthew Lee has been awarded the prestigious Hunterian Lectureship by the Royal College of Surgeons following his research into bowel obstruction.
Chair Jane Bell welcomed Dr. George to the Board and said, "Greg brings not only a high conviction in Mesoblast and our therapies but additionally important operational and strategic dimensions to our ...
Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well ...